0001199719-22-000065.txt : 20220822
0001199719-22-000065.hdr.sgml : 20220822
20220822132156
ACCESSION NUMBER: 0001199719-22-000065
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220819
FILED AS OF DATE: 20220822
DATE AS OF CHANGE: 20220822
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RUNKEL JOHN F JR
CENTRAL INDEX KEY: 0001206990
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19807
FILM NUMBER: 221183084
MAIL ADDRESS:
STREET 1: C/O INTUITIVE SURGICAL, INC.
STREET 2: 1266 KIFER ROAD
CITY: SUNNYVALE
STATE: CA
ZIP: 94086
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SYNOPSYS INC
CENTRAL INDEX KEY: 0000883241
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372]
IRS NUMBER: 561546236
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1031
BUSINESS ADDRESS:
STREET 1: 690 E MIDDLEFIELD RD
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
BUSINESS PHONE: 6505845000
MAIL ADDRESS:
STREET 1: 690 E MIDDLEFIELD RD
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94043
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2022-08-19
0
0000883241
SYNOPSYS INC
SNPS
0001206990
RUNKEL JOHN F JR
690 EAST MIDDLEFIELD ROAD
MOUNTAIN VIEW
CA
94043
0
1
0
0
GC & Corporate Secretary
Common Stock
2022-08-19
4
M
0
569
234.17
A
23192
D
Common Stock
2022-08-19
4
S
0
569
365.488
D
22623
D
Common Stock
2022-08-19
4
M
0
1572
135.88
A
24195
D
Common Stock
2022-08-19
4
S
0
1572
365.488
D
22623
D
Common Stock
2022-08-19
4
M
0
1323
89.76
A
23946
D
Common Stock
2022-08-19
4
S
0
1323
365.488
D
22623
D
Non-Qualified Stock Option (right to buy)
89.76
2022-08-19
4
M
0
1323
0.0
D
2019-12-12
2025-12-12
Common Stock
1323
2646
D
Non-Qualified Stock Option (right to buy)
135.88
2022-08-19
4
M
0
1572
0.0
D
2020-12-12
2026-12-12
Common Stock
1572
9432
D
Non-Qualified Stock Option (right to buy)
234.17
2022-08-19
4
M
0
569
0.0
D
2021-12-10
2027-12-10
Common Stock
569
5695
D
Represents a weighted average sale price per share. These shares were sold in multiple transactions at prices ranging from $361.89 to $368.85. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares purchased at each separate price within the range.
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
1/4 of the grant becomes exercisable one year after grant date with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date.
By: POA pursuant Christina Escalante-Dutra For: John Frederick Runkel, Jr.
2022-08-22